Soleymani is developing miniaturized, real-time biological sensors that could redefine personalized health management.
It's been five years since the start of the COVID-19 pandemic. McMaster experts are developing a better vaccine, using AI to power drug discovery, and sharing evidence-based ways to protect the health of communities and the economy.
The AeroVax study will test needle-free vaccines that proved more effective than traditional injected vaccines in pre-clinical studies and the Phase 1 trial.
McMaster logo
McMaster logo
